Jacobson Pharma Corporation Limited

HKEX:2633.HK

0.75 (HKD) • At close November 14, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) HKD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q32014 Q22014 Q12013 Q42013 Q3
Omzet 752.88714.918968.226817.353845.13750.413750.49695.425699.773871.686816.26805.652743.032680.508575.449565.674518.182236.898236.898231.545231.545231.545231.545
Kosten van de omzet 433.484413.839561.483476.924497.45477.571455.664429.168368.312513.169497.566466.894464.128368.232330.837298.349297.752140.721140.721125.335125.335125.335125.335
Brutowinst 319.396301.079406.743340.429347.68272.842294.826266.257331.461358.517318.694338.758278.904312.276244.612267.325220.4396.17796.177106.211106.211106.211106.211
Brutowinstmarge 0.4240.4210.420.4170.4110.3640.3930.3830.4740.4110.390.420.3750.4590.4250.4730.4250.4060.4060.4590.4590.4590.459
Onderzoek- en ontwikkelingskosten 6.4502.12107.5910000001.9064.2346.0910.2513.9641.673000000
Algemene en administratieve kosten 105.86797.82135.08577.926119.56893.978098.749097.07382.29786.21385.9460.77297.86985.63273.40562.96862.96866.77466.77466.77466.774
Verkoop- en marketingkosten 63.91564.775104.64154.39295.49688.591091.73092.20383.23383.11383.96272.74972.60165.48368.324-0.46-0.46-0.455-0.455-0.455-0.455
Verkoop-, algemene en administratieve kosten 169.782162.595239.726188.344215.064182.569192.142183.437200.005194.936165.53169.326169.902133.521170.47151.115141.72962.50862.50866.3266.3266.3266.32
Overige kosten -23.9890000000000000000000000
Bedrijfskosten 152.243162.595239.726188.344215.064182.569192.142183.437200.005194.936159.496158.15166.231155.439167.926164.642140.7762.50862.50866.3266.3266.3266.32
Bedrijfsresultaat 167.153138.484167.017152.085132.61690.273102.68482.82131.456163.581154.429170.261109.848179.75274.434116.85479.10333.66933.66939.89139.89139.89139.891
Bedrijfsresultaat ratio 0.2220.1940.1720.1860.1570.120.1370.1190.1880.1880.1890.2110.1480.2640.1290.2070.1530.1420.1420.1720.1720.1720.172
Totaal overige inkomsten en kosten netto -31.43-47.445-2.488-9.359-12.822-12.865-7.713-15.7-25.754-6.022-27.218-32.131-11.394-12.091-1.905-0.363-2.160.3650.36514.34614.34614.34614.346
Inkomen voor belasting 135.723118.528164.529178.786131.195104.00694.971131.125105.702157.156127.211152.39398.83144.82376.423104.55678.44134.03434.03454.23754.23754.23754.237
Inkomen voor belasting ratio 0.180.1660.170.2190.1550.1390.1270.1890.1510.180.1560.1890.1330.2130.1330.1850.1510.1440.1440.2340.2340.2340.234
Belastingkosten 22.83521.57927.14629.424.68119.04718.90115.36317.82328.20223.83530.56115.76222.85317.13318.31312.0225.5395.5398.0628.0628.0628.062
Nettowinst 112.928125.823114.852136.19297.62780.03971.2102.51388.413127.21897.531121.94180.329122.27657.05284.4761.1425.47625.47643.08943.08943.08943.089
Nettowinstmarge 0.150.1760.1190.1670.1160.1070.0950.1470.1260.1460.1190.1510.1080.180.0990.1490.1180.1080.1080.1860.1860.1860.186
WPA (Winst Per Aandeel) 0.0590.0660.060.0710.0510.0420.0370.0540.0460.0630.0530.0670.0440.0680.0430.0650.0470.0150.0150.0250.0250.0250.025
Verwaterde WPA 0.0590.0660.060.0710.0510.0420.0370.0540.0460.0630.0530.0670.0440.0680.0430.0650.0470.0150.0150.0250.0250.0250.025
EBITDA 248.122200.229301.469293.751239.032214.453212.164235.777210.63254.307218.249240.552166.254206.387106.942154.173109.15344.92844.92863.64263.64263.64263.642
EBITDA ratio 0.330.2940.2670.2990.2690.250.2740.2470.3020.2860.2610.2770.2240.3330.1860.2730.2110.190.190.2750.2750.2750.275